BIO vs MDLZ · rev $651.0M vs P/E 30, rev $38.54B
BIO (BIO) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
BIO currently screens at market cap $0. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the BIO and MDLZ stock pages for the full models.
Not investment advice.